BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34099864)

  • 21. Meta-analysis of miRNA expression profiles for prostate cancer recurrence following radical prostatectomy.
    Pashaei E; Pashaei E; Ahmady M; Ozen M; Aydin N
    PLoS One; 2017; 12(6):e0179543. PubMed ID: 28651018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated expression of prostate cancer-associated genes is linked to down-regulation of microRNAs.
    Erdmann K; Kaulke K; Thomae C; Huebner D; Sergon M; Froehner M; Wirth MP; Fuessel S
    BMC Cancer; 2014 Feb; 14():82. PubMed ID: 24517338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNAs and zinc metabolism-related gene expression in prostate cancer cell lines treated with zinc(II) ions.
    Hlavna M; Raudenska M; Hudcova K; Gumulec J; Sztalmachova M; Tanhäuserova V; Babula P; Adam V; Eckschlager T; Kizek R; Masarik M
    Int J Oncol; 2012 Dec; 41(6):2237-44. PubMed ID: 23064315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of MicroRNA-Related Tumorigenesis Variants and Genes in the Cancer Genome Atlas (TCGA) Data.
    Li C; Wu B; Han H; Zhao J; Bai Y; Liu X
    Genes (Basel); 2020 Aug; 11(9):. PubMed ID: 32824926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA alteration and putative target genes in high-grade prostatic intraepithelial neoplasia and prostate cancer: STAT3 and ZEB1 are upregulated during prostate carcinogenesis.
    Cha YJ; Lee JH; Han HH; Kim BG; Kang S; Choi YD; Cho NH
    Prostate; 2016 Jul; 76(10):937-47. PubMed ID: 27017949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic variants in microRNA genes and targets associated with cardiovascular disease risk factors in the African-American population.
    Li C; Grove ML; Yu B; Jones BC; Morrison A; Boerwinkle E; Liu X
    Hum Genet; 2018 Jan; 137(1):85-94. PubMed ID: 29264654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered miRNA expression in high-fat diet-induced prostate cancer progression.
    Nara T; Narita S; Mingguo H; Yoshioka T; Koizumi A; Numakura K; Tsuruta H; Maeno A; Saito M; Inoue T; Tsuchiya N; Satoh S; Habuchi T
    Carcinogenesis; 2016 Dec; 37(12):1129-1137. PubMed ID: 27915273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Common genetic variants in miR-1206 (8q24.2) and miR-612 (11q13.3) affect biogenesis of mature miRNA forms.
    Kim HK; Prokunina-Olsson L; Chanock SJ
    PLoS One; 2012; 7(10):e47454. PubMed ID: 23077621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple-to-multiple relationships between microRNAs and target genes in gastric cancer.
    Hashimoto Y; Akiyama Y; Yuasa Y
    PLoS One; 2013; 8(5):e62589. PubMed ID: 23667495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression profile analysis of microRNAs in prostate cancer by next-generation sequencing.
    Song C; Chen H; Wang T; Zhang W; Ru G; Lang J
    Prostate; 2015 Apr; 75(5):500-16. PubMed ID: 25597612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-throughput sequencing of small RNA transcriptomes reveals critical biological features targeted by microRNAs in cell models used for squamous cell cancer research.
    Severino P; Oliveira LS; Torres N; Andreghetto FM; Klingbeil Mde F; Moyses R; Wünsch-Filho V; Nunes FD; Mathor MB; Paschoal AR; Durham AM
    BMC Genomics; 2013 Oct; 14():735. PubMed ID: 24160351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer.
    Jalava SE; Urbanucci A; Latonen L; Waltering KK; Sahu B; Jänne OA; Seppälä J; Lähdesmäki H; Tammela TL; Visakorpi T
    Oncogene; 2012 Oct; 31(41):4460-71. PubMed ID: 22266859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Genome-Wide Scan for MicroRNA-Related Genetic Variants Associated With Primary Open-Angle Glaucoma.
    Ghanbari M; Iglesias AI; Springelkamp H; van Duijn CM; Ikram MA; Dehghan A; Erkeland SJ; Klaver CCW; Meester-Smoor MA;
    Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5368-5377. PubMed ID: 29049738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-93/miR-375: Diagnostic Potential, Aggressiveness Correlation and Common Target Genes in Prostate Cancer.
    Ciszkowicz E; Porzycki P; Semik M; Kaznowska E; Tyrka M
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32784653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrated analysis of miRNA landscape and cellular networking pathways in stage-specific prostate cancer.
    Verma S; Pandey M; Shukla GC; Singh V; Gupta S
    PLoS One; 2019; 14(11):e0224071. PubMed ID: 31756185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing.
    Chang YY; Kuo WH; Hung JH; Lee CY; Lee YH; Chang YC; Lin WC; Shen CY; Huang CS; Hsieh FJ; Lai LC; Tsai MH; Chang KJ; Chuang EY
    Mol Cancer; 2015 Feb; 14():36. PubMed ID: 25888956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility.
    Nicoloso MS; Sun H; Spizzo R; Kim H; Wickramasinghe P; Shimizu M; Wojcik SE; Ferdin J; Kunej T; Xiao L; Manoukian S; Secreto G; Ravagnani F; Wang X; Radice P; Croce CM; Davuluri RV; Calin GA
    Cancer Res; 2010 Apr; 70(7):2789-98. PubMed ID: 20332227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single nucleotide variation in the TP53 3' untranslated region in diffuse large B-cell lymphoma treated with rituximab-CHOP: a report from the International DLBCL Rituximab-CHOP Consortium Program.
    Li Y; Gordon MW; Xu-Monette ZY; Visco C; Tzankov A; Zou D; Qiu L; Montes-Moreno S; Dybkaer K; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huang Q; Ai W; Ponzoni M; Ferreri AJ; Winter JN; Go RS; Piris MA; Møller MB; Wu L; Wang M; Ramos KS; Medeiros LJ; Young KH
    Blood; 2013 May; 121(22):4529-40. PubMed ID: 23515929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systematic Identification of MicroRNAs That Impact on Proliferation of Prostate Cancer Cells and Display Changed Expression in Tumor Tissue.
    Aakula A; Kohonen P; Leivonen SK; Mäkelä R; Hintsanen P; Mpindi JP; Martens-Uzunova E; Aittokallio T; Jenster G; Perälä M; Kallioniemi O; Östling P
    Eur Urol; 2016 Jun; 69(6):1120-8. PubMed ID: 26489476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Global gene expression analysis reveals reduced abundance of putative microRNA targets in human prostate tumours.
    Sun R; Fu X; Li Y; Xie Y; Mao Y
    BMC Genomics; 2009 Feb; 10():93. PubMed ID: 19245699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.